Literature DB >> 23878282

Measurement of myocardial extracellular volume fraction by using equilibrium contrast-enhanced CT: validation against histologic findings.

Steve Bandula1, Steven K White, Andrew S Flett, David Lawrence, Francesca Pugliese, Michael T Ashworth, Shonit Punwani, Stuart A Taylor, James C Moon.   

Abstract

PURPOSE: To develop and validate equilibrium contrast material-enhanced computed tomography (CT) to measure myocardial extracellular volume (ECV) fraction by using a histologic reference standard and to compare equilibrium CT with equilibrium contrast-enhanced magnetic resonance (MR) imaging.
MATERIALS AND METHODS: A local ethics committee approved the study, and all subjects gave fully informed written consent. An equilibrium CT protocol was developed using iohexol at 300 mg of iodine per milliliter (bolus of 1 mg per kilogram of body weight administered at a rate of 3 mL/sec, followed immediately by an infusion of 1.88 mL/kg per hour with CT imaging before and at 25 minutes after injection of bolus of contrast agent) and ECV within the myocardial septum measured using both equilibrium CT and equilibrium MR imaging in patients with severe aortic stenosis. Biopsy samples of the myocardial septum collected during valve replacement surgery were used for histologic quantification of extracellular fibrosis with picrosirius red staining. Equilibrium CT- and equilibrium MR imaging-derived ECV measurements were compared with histologically quantified fibrosis by using Pearson correlation. Agreement between equilibrium CT and equilibrium MR imaging was assessed by using Bland-Altman comparison.
RESULTS: Twenty-three patients (16 male, seven female; mean age, 70.8 years; standard deviation, 8.3) were recruited. The mean percentage of histologic fibrosis was 18% (intersubject range, 5%-40%). There was a significant correlation between both equilibrium CT- and equilibrium MR imaging-derived ECV and percentage of histologic fibrosis (r = 0.71 [P < .001] and r = 0.84 [P < .0001], respectively). Equilibrium CT-derived ECV was significantly correlated to equilibrium MR imaging-derived ECV (r = 0.73).
CONCLUSION: ECV measured by using equilibrium CT in patients with aortic stenosis correlates with histologic quantification of myocardial fibrosis and with ECV derived by using equilibrium MR imaging. RSNA, 2013

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23878282     DOI: 10.1148/radiology.13130130

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  41 in total

Review 1.  The right ventricle and pulmonary hypertension.

Authors:  Mariëlle C van de Veerdonk; Harm J Bogaard; Norbert F Voelkel
Journal:  Heart Fail Rev       Date:  2016-05       Impact factor: 4.214

Review 2.  Tissue characterization of the myocardium: state of the art characterization by magnetic resonance and computed tomography imaging.

Authors:  Puskar Pattanayak; David A Bleumke
Journal:  Radiol Clin North Am       Date:  2014-12-18       Impact factor: 2.303

Review 3.  Magnetic resonance imaging and multi-detector computed tomography assessment of extracellular compartment in ischemic and non-ischemic myocardial pathologies.

Authors:  Maythem Saeed; Steven W Hetts; Robert Jablonowski; Mark W Wilson
Journal:  World J Cardiol       Date:  2014-11-26

4.  Hypertrophic cardiomyopathy in cardiac CT: a validation study on the detection of intramyocardial fibrosis in consecutive patients.

Authors:  C Langer; M Lutz; M Eden; M Lüdde; M Hohnhorst; C Gierloff; M Both; W Burchert; L Faber; D Horstkotte; N Frey; C Prinz
Journal:  Int J Cardiovasc Imaging       Date:  2014-01-22       Impact factor: 2.357

5.  Extracellular volume fraction determined by equilibrium contrast-enhanced multidetector computed tomography as a prognostic factor in unresectable pancreatic adenocarcinoma treated with chemotherapy.

Authors:  Yoshihiko Fukukura; Yuichi Kumagae; Ryutaro Higashi; Hiroto Hakamada; Koji Takumi; Kosei Maemura; Michiyo Higashi; Kiyohisa Kamimura; Masanori Nakajo; Takashi Yoshiura
Journal:  Eur Radiol       Date:  2018-06-19       Impact factor: 5.315

6.  Correlation of native T1 mapping with right ventricular function and pulmonary haemodynamics in patients with chronic thromboembolic pulmonary hypertension before and after balloon pulmonary angioplasty.

Authors:  F C Roller; S Kriechbaum; A Breithecker; C Liebetrau; M Haas; C Schneider; A Rolf; S Guth; E Mayer; C Hamm; G A Krombach; C B Wiedenroth
Journal:  Eur Radiol       Date:  2018-08-29       Impact factor: 5.315

7.  Extracellular volume fraction determined by equilibrium contrast-enhanced dual-energy CT as a prognostic factor in patients with stage IV pancreatic ductal adenocarcinoma.

Authors:  Yoshihiko Fukukura; Yuichi Kumagae; Ryutaro Higashi; Hiroto Hakamada; Masatoyo Nakajo; Kosei Maemura; Shiho Arima; Takashi Yoshiura
Journal:  Eur Radiol       Date:  2019-11-14       Impact factor: 5.315

8.  Prognostic Value of Computed Tomography-Derived Extracellular Volume in TAVR Patients With Low-Flow Low-Gradient Aortic Stenosis.

Authors:  Balaji Tamarappoo; Donghee Han; Jeffrey Tyler; Tarun Chakravarty; Yuka Otaki; Robert Miller; Evann Eisenberg; Siddharth Singh; Takahiro Shiota; Robert Siegel; Jasminka Stegic; Tracy Salseth; Wen Cheng; Damini Dey; Louise Thomson; Daniel Berman; John Friedman; Raj Makkar
Journal:  JACC Cardiovasc Imaging       Date:  2020-10-28

9.  Native T1 mapping and extracellular volume fraction measurement for assessment of right ventricular insertion point and septal fibrosis in chronic thromboembolic pulmonary hypertension.

Authors:  Fritz C Roller; Christoph Wiedenroth; Andreas Breithecker; Christoph Liebetrau; Eckhard Mayer; Christian Schneider; Andreas Rolf; Christian Hamm; Gabriele A Krombach
Journal:  Eur Radiol       Date:  2016-09-20       Impact factor: 5.315

10.  Non-contrast estimation of diffuse myocardial fibrosis with dual energy CT: A phantom study.

Authors:  Vidhya Kumar; Kevin E McElhanon; James K Min; Xin He; Zhaobin Xu; Eric X Beck; Orlando P Simonetti; Noah Weisleder; Subha V Raman
Journal:  J Cardiovasc Comput Tomogr       Date:  2017-12-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.